Undervalued Large-Cap Stocks on NAS November 2024

November 22, 2024

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Large-Cap

Large-Cap stocks have a market capitalization of $10 billion or more.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks on the NAS

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
CAR Avis Budget Gr 101.64 246.41 142.43 821978 3629 0.00 9.1
MRNA Moderna 38.25 90.97 137.83 9047527 15262 0.00 0.0
GT Goodyear Tire & Rubber 9.29 19.72 112.28 5500101 2666 0.00 0.0
NBIS Nebius Group 22.00 43.37 97.13 5803455 4385 0.00 0.0
NEOG Neogen 14.58 27.63 89.53 1551093 3159 0.00 0.0
BBIO BridgeBio Pharma 23.24 41.51 78.59 1745865 4381 0.00 0.0
MLCO Melco Resorts and Enter 6.06 10.50 73.27 3261637 2617 0.00 0.0
IOVA Iovance Biotherapeutics 8.24 13.56 64.52 8382406 2499 0.00 0.0
BIIB Biogen 158.01 252.01 59.49 1703784 23085 0.00 14.3
GMAB Genmab 20.47 32.42 58.38 1480585 13082 0.00 20.0
All data provided as at market close November 20, 2024.

Company Details

Avis Budget Gr

CAR:NAS

Close Price

101.64

Our Valuation

246.41

% Difference

142.43

Market Cap ($M)

3629

P/E Ratio

9.1

Avis Budget Group Inc is a provider of automotive vehicle rental and car-sharing services. Its brands include Avis, Budget, and Zipcar. Avis is targeted to serve the premium commercial and leisure segments of the travel industry, while Budget is focused on value-conscious customers. The company operates its own network of rental locations and licenses its brands to franchisees. Zipcar is a car-sharing service that allows members to use the company-owned Zipcar fleet at an hourly rate.

Access the stockcalc valuation


Moderna

MRNA:NAS

Close Price

38.25

Our Valuation

90.97

% Difference

137.83

Market Cap ($M)

15262

P/E Ratio

0.0

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Access the stockcalc valuation


Goodyear Tire & Rubber

GT:NAS

Close Price

9.29

Our Valuation

19.72

% Difference

112.28

Market Cap ($M)

2666

P/E Ratio

0.0

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.

Access the stockcalc valuation


Nebius Group

NBIS:NAS

Close Price

22.00

Our Valuation

43.37

% Difference

97.13

Market Cap ($M)

4385

P/E Ratio

0.0

Nebius Group NV is a tech company. It is a European provider of infrastructure and services to AI builders globally. The group builds full-stack infrastructure to service the growth of the AI industry, including the scale of GPU clusters, cloud platforms, tools, and services for developers. It has R&D hubs across Europe, North America and Israel.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Neogen

NEOG:NAS

Close Price

14.58

Our Valuation

27.63

% Difference

89.53

Market Cap ($M)

3159

P/E Ratio

0.0

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines.

Access the stockcalc valuation


BridgeBio Pharma

BBIO:NAS

Close Price

23.24

Our Valuation

41.51

% Difference

78.59

Market Cap ($M)

4381

P/E Ratio

0.0

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Access the stockcalc valuation


Melco Resorts and Enter

MLCO:NAS

Close Price

6.06

Our Valuation

10.50

% Difference

73.27

Market Cap ($M)

2617

P/E Ratio

0.0

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus.

Access the stockcalc valuation


Iovance Biotherapeutics

IOVA:NAS

Close Price

8.24

Our Valuation

13.56

% Difference

64.52

Market Cap ($M)

2499

P/E Ratio

0.0

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer.

Access the stockcalc valuation


Biogen

BIIB:NAS

Close Price

158.01

Our Valuation

252.01

% Difference

59.49

Market Cap ($M)

23085

P/E Ratio

14.3

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity.

Access the stockcalc valuation


Genmab

GMAB:NAS

Close Price

20.47

Our Valuation

32.42

% Difference

58.38

Market Cap ($M)

13082

P/E Ratio

20.0

Genmab AS is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Avis Budget Gr and Moderna are the most undervalued Large-Cap stocks on the NAS. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-large-cap-stocks-nas-november-2024
Avis Budget Gr $CAR and Moderna $MRNA are the most undervalued Large-Cap stocks on the #NAS. See the full list here: https://www.stockcalc.com/Blog/undervalued-large-cap-stocks-nas-november-2024
Avis Budget Gr and Moderna are the most undervalued Large-Cap stocks on the NAS. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-large-cap-stocks-nas-november-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.